Quiescent Pharmaceuticals Private Limited
About Quiescent Pharmaceuticals Private Limited
Data last updated:
Quiescent Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 08 April 2011.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073766.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sarath Kumar Kamavarapu and Sravya Kamavarapu.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at D.No.5 – 7 – 15/1 Flat No.101 Srinivasa Sadan Dayarguda Near Kukatpally Circle, Hyderabad, Telangana, India – 500072.
Company details
CIN history
Quiescent Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC073766. The current CIN is U24232TG2011PTC073766, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC073766 | Current |
| U24232AP2011PTC073766 | Previous |
Contact details
Quiescent Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No.5 – 7 – 15/1 Flat No.101 Srinivasa Sadan Dayarguda Near Kukatpally Circle, Hyderabad, Telangana, India – 500072
- IndustryChemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
To see the full contact details of Quiescent Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Quiescent Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Quiescent Pharmaceuticals Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Quiescent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Quiescent Pharmaceuticals Private Limited
Quiescent Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarath Kumar Kamavarapu | Director | 08 Apr 2011 | 15 Years 6 Months | As last reported |
| Sravya Kamavarapu | Director | 08 Apr 2011 | 15 Years 6 Months | As last reported |
Auditor
Quiescent Pharmaceuticals Private Limited is audited by NAVEEN KUMARKOTHAPALLI for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAVEEN KUMARKOTHAPALLI | FY 2016 | 223219 |
Shareholding
The shareholding of Quiescent Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Quiescent Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Quiescent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quiescent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Quiescent Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Quiescent Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Sarath Kumar Kamavarapu was appointed as Director on 08 Apr 2011.
Frequently asked questions
Quiescent Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Quiescent Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 08 April 2011 and is registered under CIN U24232TG2011PTC073766. The company has been struck off by the Registrar of Companies and is no longer operational.
Quiescent Pharmaceuticals had 2 directors:
- Sarath Kumar Kamavarapu - Director
- Sravya Kamavarapu - Director
The CIN (Corporate Identification Number) of Quiescent Pharmaceuticals is U24232TG2011PTC073766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Quiescent Pharmaceuticals is at D.No.5 – 7 – 151 Flat No.101 Srinivasa Sadan Dayarguda Near Kukatpally Circle, Hyderabad, Telangana, India – 500072.
Quiescent Pharmaceuticals was incorporated on 08 April 2011. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Quiescent Pharmaceuticals on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Quiescent Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Sarath Kumar Kamavarapu was appointed as Director on 08 Apr 2011. Sravya Kamavarapu was appointed as Director on 08 Apr 2011.
The compliance status of Quiescent Pharmaceuticals is active non-compliant as of 28 July 2026.